ITF Therapeutics LLC’s Post

View organization page for ITF Therapeutics LLC, graphic

2,848 followers

During the CureDuchenne FUTURES National Conference, our VP, Medical Affairs Scott Baver, PhD, will present the latest updates on our efforts to advance a therapeutic option for people living with Duchenne muscular dystrophy (DMD). Join us on Friday, May 24 at 1:30-2:15 p.m. ET. Check out the #2024FUTURES agenda for more details: https://lnkd.in/gV_6Q5er   #CureDuchenne #Duchenne #DMD #RareDiseases

  • No alternative text description for this image

To view or add a comment, sign in

Explore topics